Literature DB >> 21542353

[A molecular dynamics study of the interaction between domain I-BAR of the IRSp53 protein and negatively charged membranes].

O V Levtsova, I D Davletov, O S Sokolova, K V Shaĭtan.   

Abstract

The methods of computer simulation in full-atomic and large-grain approximations have been used to study specific interactions of the isolated domain I-BAR of the actin-binding protein IRSp53 and model membranes containing neutral phospholipids, as well as membranes containing high amounts of negatively charged PI(4,5)P2 phospholipids. It has been shown that the I-BAR domain does not interact with neutral lipids but induces the bending of the synthetic membrane rich in negatively charged phospholipids. A clusterization of charged lipids on the surface of the membrane at the sites of its interaction with the protein has been observed. This indicates that the interaction of the I-BAR protein with negatively charged lipids is of electrostatic and hydrophobic nature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21542353

Source DB:  PubMed          Journal:  Biofizika        ISSN: 0006-3029


  4 in total

1.  Mechanism of negative membrane curvature generation by I-BAR domains.

Authors:  Binod Nepal; Aliasghar Sepehri; Themis Lazaridis
Journal:  Structure       Date:  2021-09-13       Impact factor: 5.006

2.  The Role of BAR Domain Proteins in the Regulation of Membrane Dynamics.

Authors:  T B Stanishneva-Konovalova; N I Derkacheva; S V Polevova; O S Sokolova
Journal:  Acta Naturae       Date:  2016 Oct-Dec       Impact factor: 1.845

3.  Salt Bridge Formation between the I-BAR Domain and Lipids Increases Lipid Density and Membrane Curvature.

Authors:  Kazuhiro Takemura; Kyoko Hanawa-Suetsugu; Shiro Suetsugu; Akio Kitao
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

4.  Comparative computational study of interaction of C60-fullerene and tris-malonyl-C60-fullerene isomers with lipid bilayer: relation to their antioxidant effect.

Authors:  Marine E Bozdaganyan; Philipp S Orekhov; Alexey K Shaytan; Konstantin V Shaitan
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.